Inserm’s Science and Society department has published testimonies of participatory research on the Inserm website.
These exchanges are rich in lessons on collaborative research methods with civil society. The added value of this type of research is significant, for the start-up phases of projects, the human dimension of the exercise, and support for material and financial aspects.
Didier Lacombe is elected to CSS2 – Cancerology, genetic diseases.
Rodrigue Rossignol is elected to CSS3 – Physiology and physiopathology of large systems.
The CSS are consulted by the President of the Institute:
– on the appointment of directors of research units, the renewal of their functions or the decision to terminate them.
– on the creation, modification and abolition of the institute’s research units, and periodically check the activity of researchers and classify them with a view to their promotion.
The CSS are also constituted once a year as an admissibility jury in the context of recruitment competitions for research directors (DR) and research managers (CR); they select the candidates and rank them according to their merit.
Our research unit, the MRGM (Rare Diseases: Genetics and Metabolism), was evaluated by HCERES in February 2021 (group B) under the supervision of the University of Bordeaux and INSERM.
The evaluation highlighted the good quality of the publications.
The strengths are:
– the constitution of well-characterized cohorts from a phenotypic point of view.
– the establishment of appropriate therapies.
– the numerous national and international collaborations.
– the existence of a zebrafish platform.
– its good coaptation with the hospital university services and which is essential for the competitiveness of our INSERM 1211 unit.
To access the summary of our assessment, follow the link: https://www.hceres.fr/en/rechercher-une-publication/mrgm-maladies-rares-genetique-et-metabolisme-0
The MRGM together with the Department of Biological and Medical Sciences of the University of Bordeaux, have invited José Antonio Enríquez (Centro Nacional de Investigaciones Cardiovasculares – Madrid | Spain) to give a Seminar on April 14th, 2020.
Event info:
Amphitheater of the BROCCA Institute – University of Bordeaux
April 14th, 2020 at 11:00am.
Link to Enríquez Laboratory website.
An additional regulator of mitochondrial bioenergetics discovered by Rossignol’s group: the protein EIF3F stimulates OXPHOS through AMPK. A ChipSeq/Proteomics analysis.
Rare Diseases: Genetics and Metabolism 